Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

230.80
Delayed Data
As of 4:04pm ET
 -6.99 / -2.94%
Today’s Change
195.50
Today|||52-Week Range
322.68
-26.14%
Year-to-Date
Dow 30 Stock Roundup: Nike Earnings Impress, Boeing Wins $8B Saudi Order
11:03am / Zacks.com - Paid Partner Content
Allergan's Vitae buy could spark more interest in Kadmon
Sep 23 / TheStreet.com - Paid Partner Content
Are Hedge Funds Technically Wrong?
8:01am / TheStreet.com - Paid Partner Content
5 Biotech Stocks to Watch as Interest in NASH Increases
Sep 22 / Zacks.com - Paid Partner Content
Are Hedge Funds Technically Wrong?
Sep 28 / TheStreet.com - Paid Partner Content
Is Galectin The Next Takeover Target for the Biotech World?
Sep 22 / Zacks.com - Paid Partner Content
These 3 Stocks Tripled in 12 Months
Sep 28 / MotleyFool.com - Paid Partner Content
Biotech ETFs in Focus on Tobira Therapeutics' Massive Gain
Sep 21 / Zacks.com - Paid Partner Content
Pfizer (PFE) to Stay Together as a Single Company After All
Sep 27 / Zacks.com - Paid Partner Content
Stock Market News for September 21, 2016
Sep 21 / Zacks.com - Paid Partner Content
Ruane Cunniff Cuts Allergan, Berkshire, IBM
Sep 26 / GuruFocus News - Paid Partner Content
Allergan Buys NASH Therapy Maker Tobira at Huge Premium
Sep 21 / Zacks.com - Paid Partner Content
Read Scraps Pfizer Break-up As Megadeals Escape Its Grasp
Sep 26 / TheStreet.com - Paid Partner Content
Why Did Tobira Therapeutics (TBRA) Stock Skyrocket 720% Today?
Sep 20 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Deutsche Bank, Apple, Therapeutics, Allergan and G...
Sep 26 / Zacks.com - Paid Partner Content
Why DTS, SolarCity, and Tobira Therapeutics Jumped Today
Sep 20 / MotleyFool.com - Paid Partner Content
Allergan Gets FDA Approval for New Line of Breast Implants
Sep 26 / Zacks.com - Paid Partner Content
Why Tobira Therapeutics Inc Was an Overnight Octuple
Sep 20 / MotleyFool.com - Paid Partner Content
Amgen's Biosimilar of Abbvie's Humira Gets FDA Approval
Sep 26 / Zacks.com - Paid Partner Content
Sarepta jumps after drugs regulator boost
Sep 20 / FT.com - Paid Partner Content
3 Dirt-Cheap Dividend Stocks You Can Buy Right Now
Sep 24 / MotleyFool.com - Paid Partner Content
Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data
Sep 16 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Con...
Sep 23 / Zacks.com - Paid Partner Content
Coach slips on 'unhealthy manner' warning
Sep 14 / FT.com - Paid Partner Content
ETFs in Focus on the Nasdaq Rally
Sep 23 / Zacks.com - Paid Partner Content
Bayer Monsanto deal requires jumbo financing
Sep 14 / FT.com - Paid Partner Content
Allergan/Adamas Launch New Dosage Strengths of Namzaric
Sep 23 / Zacks.com - Paid Partner Content
'Middlemen' under the spotlight in EpiPen furore
Sep 09 / FT.com - Paid Partner Content
US politicians lament inaction over price-gouging drug companies
Sep 23 / FT.com - Paid Partner Content
CEO of Botox maker vows to limit price hikes
Sep 07 / CNNMoney.com
Pharma Stock Roundup: Allergan Acquisitions in Focus, J&J to Buy Abbott's AMO
Sep 23 / Zacks.com - Paid Partner Content